Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Different Doses of Domperidone in Feeding Intolerance of Premature Infant
NCT02980250Phase 4Completed
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Nov 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of domperidone in feeding intolerance (4 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: the residual glucose percentage at 7 days. Started Nov 2015; status: completed.
02
Drugs
domperidone
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on NCT02980250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02980250.